(“NetScientific” or the “Company”)
Issue of Equity
NetScientific plc (AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that to ensure that the number of Interim Ordinary Shares is exactly divisible by 10 to allow for a capital reorganisation which has the effect of consolidating ten Existing Ordinary Shares into one New Ordinary Shares and as previously announced on 5 August 2020, it is proposed that Neville Registrars is issued with 4 Existing Ordinary Shares after the General Meeting and before the Record Date, at which point the 4 Existing Ordinary Shares will be consolidated off the register immediately.
Immediately following the capital reorganisation becoming effective, the number of New Ordinary Shares will be 7,856,187.
Unless other defined, terms used in this announcement shall have the same meanings as those defined in the announcement dates 5 August 2020.
For more information, please contact:
Ilian Iliev, CEO
|Tel: +44 (0)20 3514 1800|
|WHIreland (NOMAD, Financial Adviser and Broker)
Chris Fielding / Jessica Cave / Darshan Patel
|Tel: +44 (0)20 7220 1666|
|MO PR ADVISORY (Press Contact)
|Tel: +44 (0)78 7644 4977|
NetScientific PLC is a transatlantic healthcare IP commercialisation Group focused on technologies and companies that have the potential to treat chronic disease and significantly improve the health and well-being of people.
For more information, please visit the website at www.NetScientific.net